LEADER 04199nam 22006255 450 001 9910254267803321 005 20200705173906.0 010 $a3-319-27380-9 024 7 $a10.1007/978-3-319-27380-8 035 $a(CKB)3710000000649136 035 $a(EBL)4509215 035 $a(SSID)ssj0001666039 035 $a(PQKBManifestationID)16454496 035 $a(PQKBTitleCode)TC0001666039 035 $a(PQKBWorkID)14999791 035 $a(PQKB)11592127 035 $a(DE-He213)978-3-319-27380-8 035 $a(MiAaPQ)EBC4509215 035 $a(PPN)19344609X 035 $a(EXLCZ)993710000000649136 100 $a20160419d2016 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aPET/CT in Lymphomas $eA Case-Based Atlas /$fedited by John A. Andreou, Paris A. Kosmidis, Athanasios D. Gouliamos 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (371 p.) 300 $aDescription based upon print version of record. 311 $a3-319-27378-7 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aPart I: Introduction to Lymphomas -- Advances in the Pathobiology of Lymphomas: Implication in the Diagnosis and Clinical Management -- General Principles of PET?CT Imaging -- Anatomic Classification of Lymph Nodes -- An Overview of the Clinical Evaluation of Lymphomas According to the WHO 2008 Classification -- The Role of PET/CT in Radiotherapy Planning of Lymphoma -- Part II: PET/CT in Hodgkin Lymphoma -- PET/CT in Hodgkin Lymphoma -- Part III: PET/CT in Non-Hodgkin?s Lymphomas -- Aggressive B-Cell Lymphomas -- Follicular Lymphomas -- Mantle Cell Lymphoma -- T-Cell Lymphomas -- Highly Aggressive Lymph?mas -- Splenic Lymphomas -- Central Nervous System Lymphomas -- Gastric Lymphomas -- Cutaneous Lymphomas -- Other Rare Extranodal Lymphomas -- Part IV: Lymphomas in Children and Adolescents -- Introduction -- Hodgkin?s lymphoma in Children and Adolescents -- Lymphoblastic Lymphoma in Children and Adolescents -- Burkitt and BurkittLike Lymphomas in Children and Adolescents -- Diffuse Large B Cell Lymphoma in Children and Adolescents -- Large Cell Anaplastic Lymphoma in Children and Adolescents. 330 $aDrawing on an extensive series of cases, this book describes and illustrates in detail the FDG-PET/CT appearances of the most common lymphomas in both adults and children, covering presentations at various anatomic sites. In addition, all other aspects of the current application of FDG-PET/CT in the evaluation and management of patients with malignant lymphomas are described. Full explanations are provided of the potential benefits and limitations of advanced PET/CT techniques and technologies that support novel chemotherapy and radiotherapy approaches in the treatment of lymphoma, and particular attention is paid to the major challenge of incorporating progress in quantitative imaging technology into radiotherapy treatment planning, guidance, and monitoring. This clinical case-based atlas will be an invaluable tool for radiologists, hematologists, and clinical oncologists. . 606 $aNuclear medicine 606 $aHematology 606 $aOncology   606 $aNuclear Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H29048 606 $aHematology$3https://scigraph.springernature.com/ontologies/product-market-codes/H3307X 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 615 0$aNuclear medicine. 615 0$aHematology. 615 0$aOncology  . 615 14$aNuclear Medicine. 615 24$aHematology. 615 24$aOncology. 676 $a610 702 $aAndreou$b John A$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aKosmidis$b Paris A$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGouliamos$b Athanasios D$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910254267803321 996 $aPET$92588800 997 $aUNINA